Drug Shortage Report for VESICARE
| Report ID | 208998 |
| Drug Identification Number | 02277263 |
| Brand name | VESICARE |
| Common or Proper name | Vesicare |
| Company Name | ASTELLAS PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SOLIFENACIN SUCCINATE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1 bottle, 30 tablets |
| ATC code | G04BD |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-11-03 |
| Actual start date | 2023-11-03 |
| Estimated end date | 2023-11-10 |
| Actual end date | 2023-11-10 |
| Shortage status | Resolved |
| Updated date | 2023-11-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 675 COCHRANE DRIVE, WEST TOWER MARKHAM, ONTARIO CANADA L3R 0B8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-11-11 | English | Compare |
| v7 | 2023-11-10 | French | Compare |
| v6 | 2023-11-10 | English | Compare |
| v5 | 2023-11-10 | English | Compare |
| v4 | 2023-11-04 | English | Compare |
| v3 | 2023-11-03 | French | Compare |
| v2 | 2023-11-03 | English | Compare |
| v1 | 2023-11-03 | English | Compare |
Showing 1 to 8 of 8